Find Research Outputs

Search concepts
Selected filters
2016
109 Citations (Scopus)

Attainment of LDL-cholesterol treatment goals in patients with familial hypercholesterolemia: 5-year SAFEHEART registry follow-up

Perez De Isla, L., Alonso, R., Watts, G., Mata, N., Saltijeral Cerezo, A., Muñiz, O., Fuentes, F., Diaz-Diaz, J. L., De Andrés, R., Zambón, D., Rubio-Marin, P., Barba-Romero, M. A., Saenz, P., Sanchez Muñoz-Torrero, J. F., Martinez-Faedo, C., Miramontes-Gonzalez, J. P., Badimón, L., Mata, P., Aguado, R., Almagro, F. & 21 othersArrieta, F., Barba, M. Á., Brea, Á., Cepeda, J. M., Díaz, G., Díaz, J. L., Garrido, J. A., Irigoyen, L., Manjón, L., Martin, A., Piedecausa, M., Mauri, M., Miramontes, P., Pereyra, F., Pérez, L., Pintó, X., Pujante, P., Ruiz, E., Sánchez, J. F., Vidal, J. I. & Argüeso, R., 2016, In : Journal of the American College of Cardiology. 67, 11, p. 1278-1285

Research output: Contribution to journalArticle

Open Access
Hyperlipoproteinemia Type II
LDL Cholesterol
Registries
Therapeutics
Lipids
2017
65 Citations (Scopus)

Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program)

Gaudet, D., Watts, G. F., Robinson, J. G., Minini, P., Sasiela, W. J., Edelberg, J., Louie, M. J. & Raal, F. J., 1 Jan 2017, In : American Journal of Cardiology. 119, 1, p. 40-46 7 p.

Research output: Contribution to journalArticle

Open Access
Lipoprotein(a)
Hydroxymethylglutaryl-CoA Reductase Inhibitors
LDL Cholesterol
alirocumab
Hyperlipoproteinemia Type II
2016
2 Citations (Scopus)

Diabetes, statins and FH

Fuentes, F., Alcalá-Díaz, J. F., Watts, G. F. & Mata, P., 2016, In : International Journal of Cardiology. 203, p. 575 575 p.

Research output: Contribution to journalLetter

Author reply

Pateria, P., Jeffrey, G. P., MacQuillan, G., Speers, D., Ching, H., Chinnaratha, M. A., Watts, G. F. & Adams, L. A., 2016, In : Internal Medicine Journal. 46, 7, p. 863 863 p.

Research output: Contribution to journalLetter

2017
12 Citations (Scopus)

Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study

Bos, S., Duvekot, M. H. C., ten Kate, G. J. R., Verhoeven, A. J. M., Mulder, M. T., Schinkel, A. F. L., Nieman, K., Watts, G. F., Sijbrands, E. J. G. & Roeters van Lennep, J. E., 1 Jan 2017, In : Atherosclerosis. 256, p. 62-66 5 p.

Research output: Contribution to journalArticle

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hyperlipoproteinemia Type II
Carotid Stenosis
Case-Control Studies
Carotid Artery Diseases
2016
23 Citations (Scopus)

Translational research for improving the care of familial hypercholesterolemia: The “ten countries study” and beyond

Watts, G. F., Ding, P. Y., George, P., Hagger, M. S., Hu, M., Lin, J., Khoo, K. L., Marais, A. D., Miida, T., Nawawi, H. M., Pang, J., Park, J. E., Gonzalez-Santos, L. B., Su, T. C., Truong, T. H., Santos, R. D., Soran, H., Yamashita, S., Tomlinson, B., Arikketh, D. & 31 othersAshavaid, T. F., Atiqah, N., Balasubramaniam, S., Chan, D. C., Chang, N. T., Do, T. C., Zhao, D., Ellis, K. L., Han, K. H., Hardcastle, S. J., Jannes, C. E., Kassim, A. M., Ismail, Z. M., Kwok, S., Lam, C. S., Lansberg, P. J., Livingston, M., Mehta, M., Muir, L., Peng, H. B., Pereira, A. C., Rahman, T. H. A., Ramli, A. S., Rangarajan, N., Razak, S. A., Sijbrands, E. J., Sullivan, D. R., Shyong Tai, E., Tan, H. C., Verma, I. C. & Wu, X., 2016, In : Journal of Atherosclerosis and Thrombosis. 23, 8, p. 891-900 10 p.

Research output: Contribution to journalReview article

Hyperlipoproteinemia Type II
Translational Medical Research
LDL Receptors
Availability
Atherosclerosis
2017
9 Citations (Scopus)
34 Citations (Scopus)

Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia

Lázaro, P., Pérez de Isla, L., Watts, G. F., Alonso, R., Norman, R., Muñiz, O., Fuentes, F., Mata, N., López-Miranda, J., González-Juanatey, J. R., Díaz-Díaz, J. L., Blasco, A. J. & Mata, P., 1 Jan 2017, In : Journal of Clinical Lipidology. 11, 1, p. 260–271

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Cost-Benefit Analysis
Quality-Adjusted Life Years
Genetic Testing
Decision Trees
2016
32 Citations (Scopus)
Hyperlipoproteinemia Type II
Coronary Disease
Cohort Studies
Cholesterol
Pregnancy
27 Citations (Scopus)

International developments in the care of familial hypercholesterolemia: Where now and where to next?

Pang, J., Lansberg, P. J. & Watts, G. F., 2016, In : Journal of Atherosclerosis and Thrombosis. 23, 5, p. 505-519 15 p.

Research output: Contribution to journalReview article

Drug therapy
Hyperlipoproteinemia Type II
Lipoproteins
Screening
Testing
4 Citations (Scopus)

Interpretative comments specifically suggesting specialist referral increase the detection of familial hypercholesterolaemia

Bender, R., Edwards, G., Mcmahon, J., Hooper, A., Watts, G., Burnett, J. & Bell, D., 2016, In : Pathology. 48, 5, p. 463-466

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Telefacsimile
LDL Cholesterol
Referral and Consultation
Genetic Testing
10 Citations (Scopus)
243 Downloads (Pure)
Open Access
File
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hyperlipoproteinemia Type II
Elasticity
Omega-3 Fatty Acids
Blood Pressure
2018
3 Citations (Scopus)

Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families

Truong, T. H., Kim, N. T., Nguyen, M. N. T., Pang, J., Hooper, A. J., Watts, G. F. & Do, D. L., Oct 2018, In : Atherosclerosis. 277, p. 392-398 7 p.

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Vietnam
Genetic Testing
LDL Receptors
Mutation
13 Citations (Scopus)

Lipoprotein(a) and secondary prevention of atherothrombotic events: A critical appraisal

Boffa, M. B., Stranges, S., Klar, N., Moriarty, P. M., Watts, G. F. & Koschinsky, M. L., 1 Nov 2018, In : Journal of Clinical Lipidology. 12, 6, p. 1358-1366 9 p.

Research output: Contribution to journalReview article

Lipoprotein(a)
Secondary Prevention
Preexisting Condition Coverage
Population
Coronary Disease
2019
5 Citations (Scopus)

PCSK9 monoclonal antibodies and lipoprotein apheresis for lowering lipoprotein(a): making choices in an era of RNA-based therapies

Ruscica, M., Watts, G. F. & Sirtori, C. R., Jun 2019, In : European Journal of Preventive Cardiology. 26, 9, p. 998-1000 3 p.

Research output: Contribution to journalEditorial

2016
8 Citations (Scopus)

Ten years of lipoprotein apheresis for familial hypercholesterolemia in Malaysia: A creative approach by a cardiologist in a developing country

Khoo, K. L., Page, M. M., Liew, Y. M., Defesche, J. C. & Watts, G. F., 30 Sep 2016, In : Journal of Clinical Lipidology. 10, 5, p. 1188-1194 7 p.

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Blood Component Removal
Malaysia
Developing Countries
Lipoproteins
55 Citations (Scopus)

The impact of statin therapy on plasma levels of von Willebrand factor antigen: Systematic review and meta-analysis of Randomised placebo-controlled trials

Sahebkar, A., Serban, C., Ursoniu, S., Mikhailidis, D. P., Undas, A., Lip, G. Y. H., Bittner, V., Ray, K. K., Watts, G. F., Kees Hovingh, G., Rysz, J., Kastelein, J. J. P. & Banach, M., 2016, In : Thrombosis and Haemostasis. 115, 3, p. 520-532 13 p.

Research output: Contribution to journalReview article

Hydroxymethylglutaryl-CoA Reductase Inhibitors
von Willebrand Factor
Meta-Analysis
Randomized Controlled Trials
Placebos
17 Citations (Scopus)

Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes

Negrulj, R., Mooranian, A., Chen-Tan, N., Al-Sallami, H. S., Mikov, M., Golocorbin-Kon, S., Fakhoury, M., Watts, G., Arfuso, F. & Al-Salami, H., 2016, In : Artificial Cells, Nanomedicine and Biotechnology. 44, 5, p. 1290-1297

Research output: Contribution to journalArticle

Probucol
Deoxycholic Acid
Medical problems
Bile Acids and Salts
Strength of materials
9 Citations (Scopus)

Efficacy and Safety of Evacetrapib for Modifying Plasma Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Sahebkar, A., Simental-Mendía, L. E., Guerrero-Romero, F., Golledge, J. & Watts, G., 2016, In : Current Pharmaceutical Design. 22, 5, p. 595-608 14 p.

Research output: Contribution to journalArticle

evacetrapib
Lipid A
Meta-Analysis
Randomized Controlled Trials
Safety
2019
4 Citations (Scopus)

Recent advances in synthetic pharmacotherapies for dyslipidaemias

Sirtori, C. R., Yamashita, S., Francesca Greco, M., Corsini, A., F Watts, G. & Ruscica, M., 6 May 2019, In : European Journal of Preventive Cardiology.

Research output: Contribution to journalReview article

Open Access
Dyslipidemias
LDL Cholesterol
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypertriglyceridemia
Drug Therapy
3 Citations (Scopus)
Open Access
Apoprotein(a)
Lipoprotein(a)
Protein Isoforms
Cholesterol
Therapeutics
2017
39 Citations (Scopus)

Personal model-assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD

Mardinoglu, A., Bjornson, E., Zhang, C., Klevstig, M., Söderlund, S., Ståhlman, M., Adiels, M., Hakkarainen, A., Lundbom, N., Kilicarslan, M., Hallström, B. M., Lundbom, J., Vergès, B., Barrett, P. H. R., Watts, G. F., Serlie, M. J., Nielsen, J., Uhlén, M., Smith, U., Marschall, H. U. & 2 othersTaskinen, M. R. & Boren, J., 1 Mar 2017, In : Molecular Systems Biology. 13, 3, 916.

Research output: Contribution to journalArticle

Open Access
fatty liver
Metabolism
Liver
NAD
Identification (control systems)
2019

Familial Hypercholesterolaemia in 2020: A Leading Tier 1 Genomic Application

Pang, J., Sullivan, D. R., Brett, T., Kostner, K. M., Hare, D. L. & Watts, G. F., 24 Dec 2019, In : Heart, Lung and Circulation.

Research output: Contribution to journalReview article

Hyperlipoproteinemia Type II
Coronary Artery Disease
LDL Cholesterol
Parturition
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2018
9 Citations (Scopus)
Coronary Care Units
Hyperlipoproteinemia Type II
Lipoprotein(a)
Coronary Artery Disease
Acute Coronary Syndrome
2019
15 Citations (Scopus)

Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia

Ellis, K. L., Pérez de Isla, L., Alonso, R., Fuentes, F., Watts, G. F. & Mata, P., 12 Mar 2019, In : Journal of the American College of Cardiology. 73, 9, p. 1029-1039 11 p.

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Lipoprotein(a)
Cardiovascular Diseases
2018
9 Citations (Scopus)
coenzyme Q10
Inflammation Mediators
Leukotrienes
Omega-3 Fatty Acids
Chronic Renal Insufficiency
2017
6 Citations (Scopus)

Increasing the Detection of Familial Hypercholesterolaemia Using General Practice Electronic Databases

Vickery, A. W., Ryan, J., Pang, J., Garton-Smith, J. & Watts, G. F., 1 May 2017, In : Heart, Lung and Circulation. 26, 5, p. 450-454 5 p.

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
General Practice
Databases
Electronic Health Records
LDL Cholesterol
2 Citations (Scopus)

Statins, PCSK9 inhibitors and cholesterol homeostasis: a view from within the hepatocyte

Sniderman, A. D., Kiss, R. S., Reid, T., Thanassoulis, G. & Watts, G. F., 1 May 2017, In : Clinical Science. 131, 9, p. 791-797 7 p.

Research output: Contribution to journalArticle

Anticholesteremic Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hepatocytes
Homeostasis
Cholesterol
2018
36 Citations (Scopus)
2016
10 Citations (Scopus)

The association between chronic hepatitis C infection and cardiovascular risk

Pateria, P., Jeffrey, G., Macquillan, G., Speers, D., Ching, H., Chinnaratha, M. A., Watts, G. & Adams, L., 2016, In : Internal Medicine Journal. 46, 1, p. 63-70

Research output: Contribution to journalArticle

Cardiovascular Infections
Chronic Hepatitis C
Vascular Stiffness
Carotid Intima-Media Thickness
Vascular Diseases
2018
1 Citation (Scopus)

THE EFFECTS OF OMEGA-3 FATTY ACIDS ON INFLAMMATION, PRO-ATHEROGENIC CYTOKINES AND LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN CHRONIC KIDNEY DISEASE PATIENTS

Yong, K., Mori, T., Chew, G., Beilin, L., Puddey, I., Watts, G., Irish, A., Dogra, G., Boudville, N. & Lim, W., Sep 2018, In : Nephrology. 23, p. 45-45 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

2019
11 Citations (Scopus)

Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text

Kolovou, G. D., Watts, G. F., Mikhailidis, D. P., Pérez-Martínez, P., Mora, S., Bilianou, H., Panotopoulos, G., Katsiki, N., Ooi, T. C., Lopez-Miranda, J., Tybjærg-Hansen, A., Tentolouris, N. & Nordestgaard, B. G., 1 Jan 2019, In : Current Vascular Pharmacology. 17, 5, p. 498-514 17 p.

Research output: Contribution to journalArticle

Hypertriglyceridemia
Lipids
Fats
Fasting
Triglycerides
2016
22 Citations (Scopus)

PCSK9 inhibitors - mechanisms of action

Page, M. M. & Watts, G. F., Oct 2016, In : Australian Prescriber. 39, 5, p. 164-167 4 p.

Research output: Contribution to journalArticle

Open Access
LDL Cholesterol
LDL Receptors
Proprotein Convertases
Mutation
Hyperlipoproteinemia Type II
2019
1 Citation (Scopus)

A new dawn for managing dyslipidemias: The era of rna-based therapies

Macchi, C., Sirtori, C. R., Corsini, A., Santos, R. D., Watts, G. F. & Ruscica, M., 1 Dec 2019, In : Pharmacological Research. 150, 104413.

Research output: Contribution to journalReview article

Dyslipidemias
RNA
LDL Cholesterol
Lipoprotein(a)
Cardiovascular Diseases
2018

Editorial introductions (in Current Opinion in Lipidology)

Stroes, E. S. G. & Watts, G. F., Dec 2018, In : Current Opinion in Lipidology. 29, 6, p. 433-433 1 p.

Research output: Contribution to journalEditorial

2019
2 Citations (Scopus)

A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolaemia: the Sino-Roman Study

Stefanutti, C., Pang, J., Di Giacomo, S., Wu, X., Wang, X., Morozzi, C., Watts, G. F. & Lin, J., Jul 2019, In : Journal of Clinical Lipidology. 13, 4, p. 608-617

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Blood Component Removal
LDL Cholesterol
Survival
Lipoproteins
7 Citations (Scopus)

Comparative aspects of the care of familial hypercholesterolemia in the “Ten Countries Study”

Pang, J., Chan, D. C., Hu, M., Muir, L. A., Kwok, S., Charng, M. J., Florkowski, C. M., George, P. M., Lin, J., Loi, D. D., Marais, A. D., Nawawi, H. M., Gonzalez-Santos, L. E., Su, T. C., Truong, T. H., Santos, R. D., Soran, H., Tomlinson, B., Yamashita, S., Ademi, Z. & 1 othersWatts, G. F., Apr 2019, In : Journal of Clinical Lipidology. 13, 2, p. 287-300

Research output: Contribution to journalArticle

Hyperlipoproteinemia Type II
Delivery of Health Care
Genetic Testing
Education
Developing Countries
2019
2 Citations (Scopus)

Improving the detection of familial hypercholesterolaemia

Lan, N. S. R., Martin, A. C., Brett, T., Watts, G. F. & Bell, D. A., Feb 2019, In : Pathology. 51, 2, p. 213-221 9 p.

Research output: Contribution to journalReview article

2017
1 Citation (Scopus)

Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid management

Mancini, G. B. J., Gupta, M., Tsigoulis, M., Cannon, C. P., Genest, J., Ray, K. K., Santos, R. D., Watts, G. F. & Raggi, P., 1 Aug 2017, In : Atherosclerosis. 263, p. 112-118 7 p.

Research output: Contribution to journalArticle

Open Access
Cardiovascular Diseases
Lipids
Chronic Renal Insufficiency
Type 2 Diabetes Mellitus
Physicians
2019
1 Citation (Scopus)

What's new on therapies for elevated lipoprotein(a)

Ward, N. C., Schultz, C. J. & Watts, G. F., 3 Jun 2019, In : Expert Review of Clinical Pharmacology. 12, 6, p. 495-499 5 p.

Research output: Contribution to journalEditorial

Lipoprotein(a)
Software
Molecular Sequence Annotation
Protein Databases
Peptides
2018
Blood Platelets
Exercise
Platelet Activation
Brachial Artery
Acute Coronary Syndrome
2019
13 Citations (Scopus)

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation

Fruchart, J-C., Santos, R. D., Aguilar-Salinas, C., Aikawa, M., Al Rasadi, K., Amarenco, P., Barter, P. J., Ceska, R., Corsini, A., Despres, J-P., Duriez, P., Eckel, R. H., Ezhov, M. V., Farnier, M., Ginsberg, H. N., Hermans, M. P., Ishibashi, S., Karpe, F., Kodama, T., Koenig, W. & 35 othersKrempf, M., Lim, S., Lorenzatti, A. J., McPherson, R., Millan Nunez-Cortes, J., Nordestgaard, B. G., Ogawa, H., Packard, C. J., Plutzky, J., Ponte-Negretti, C. I., Pradhan, A., Ray, K. K., Reiner, Z., Ridker, P. M., Ruscica, M., Sadikot, S., Shimano, H., Sritara, P., Stock, J. K., Su, T-C., Susekov, A. V., Tartar, A., Taskinen, M-R., Tenenbaum, A., Tokgozoglu, L. S., Tomlinson, B., Tybjaerg-Hansen, A., Valensi, P., Vrablik, M., Wahli, W., Watts, G. F., Yamashita, S., Yokote, K., Zambon, A. & Libby, P., 4 Jun 2019, In : Cardiovascular Diabetology. 18, 1, 20 p., 71.

Research output: Contribution to journalReview article

Open Access
2017
16 Citations (Scopus)

Knowns and unknowns in the care of pediatric familial hypercholesterolemia

Martin, A. C., Gidding, S. S., Wiegman, A. & Watts, G. F., Sep 2017, In : Journal of Lipid Research. 58, 9, p. 1765-1776 12 p.

Research output: Contribution to journalArticle

2018
48 Citations (Scopus)

The Role of Nutraceuticals in Statin Intolerant Patients

International Lipid Expert Panel (ILEP), 3 Jul 2018, In : Journal of the American College of Cardiology. 72, 1, p. 96-118 23 p.

Research output: Contribution to journalReview article

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Dietary Supplements
Cardiovascular Diseases
Cynara scolymus
Berberine
2019
23 Citations (Scopus)

Statin Toxicity

Ward, N. C., Watts, G. F. & Eckel, R. H., 18 Jan 2019, In : Circulation Research. 124, 2, p. 328-350 23 p.

Research output: Contribution to journalArticle

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Muscles
Primary Prevention
Secondary Prevention
LDL Cholesterol
2 Citations (Scopus)

Identifying Perceptions and Preferences of the General Public Concerning Universal Screening of Children for Familial Hypercholesterolaemia

Bowman, F. L., Molster, C. M., Lister, K. J., Bauskis, A. T., Garton-Smith, J., Vickery, A. W., Watts, G. F. & Martin, A. C., 22 Jul 2019, In : Public Health Genomics.

Research output: Contribution to journalArticle

Open Access
Hyperlipoproteinemia Type II
Inborn Genetic Diseases
Genomics
Coronary Disease
Immunization
2018
7 Citations (Scopus)
Sodium Fluoride
Positron-Emission Tomography
Cardiovascular Diseases
Vascular Calcification
Calcium
2017
5 Citations (Scopus)
239 Downloads (Pure)
Open Access
File
Obesity
Hypertension
Weight Loss
Antihypertensive Agents
Therapeutics
2018
13 Citations (Scopus)
325 Downloads (Pure)
Open Access
File
Hyperlipoproteinemia Type II
Lipids
Mutation
Early Diagnosis
Xanthomatosis